Sort   by:  
 Page size 
ProteomicsDIA quantitative proteomics of CENPM knockdown SW-13 cells
The project aims to detect the differential expression of proteomics in normal SW-13 cells and CENPM knockdown SW-13 cells
ORGANISM(S): Homo Sapiens 
2024-11-19 | PXD058018 |
UnknownLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Not available
S-EPMC8822604 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
Sort   by:  
 Page size